Hospital Italiano de Buenos Aires — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Hospital Italiano de Buenos Aires appears in 25 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials25

Recruiting shown3

Roles2

SourceClinicalTrials.gov

Clinical trials

25 shown

Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated HemoglobinNCT07621419 · lead sponsor · 2025-08-04

Institutional Registry of Rare DiseasesNCT06573723 · lead sponsor · 2024-07-01

Pulmonary Hypertension Institutional Registry at Hospital Italiano de Buenos AiresNCT01501838 · lead sponsor · 2017-01-01

Pilot Study for the Evaluation of the More Stamina in Persons With Multiple SclerosisNCT04244214 · lead sponsor · 2023-01-01

Multicentric Study for External Validation of a Deep Learning Model for Mammographic Breast Density CategorizationNCT05021055 · lead sponsor · 2021-09-01

Is the Artificial Pancreas, Without Carbohydrate Counting, Efficient and Safe in an Outpatient SettingNCT04793165 · lead sponsor · 2021-03-08

Follow-up Strategies for Fragile Patients With Decompensated Heart FailureNCT04643184 · lead sponsor · 2020-12-02

Evaluation of the Relationship Between Missed Appointments and Adherence to Medical IndicationsNCT06501456 · lead sponsor · 2020-07-01

Real-world Data of Ocrelizumab in Multiple Sclerosis in LATAMNCT03784547 · lead sponsor · 2019-02-01

Multiple Sclerosis Registry in Argentina (RelevarEM)NCT03375177 · lead sponsor · 2018-03-25

Individualized Antiretroviral TherapyNCT03385473 · lead sponsor · 2017-10-05

High Flow Nasal Cannula and Aerobic Capacity TrainingNCT02973945 · lead sponsor · 2017-07-01

Efficacy of an Education Protocol in the Correction of Inhalation Techniques in COPDNCT03144557 · lead sponsor · 2017-01-02

Artificial Pancreas in Latin AmericaNCT02994277 · lead sponsor · 2016-11-01

Hospitalary Chronic Obstructive Pulmonary Disease RegistryNCT02659189 · lead sponsor · 2016-07-01

Prevalence of Respiratory Aspiration in Patients With COPDNCT02722629 · lead sponsor · 2016-06-01

Association Between Testosterone Levels and COPD SeverityNCT02824809 · lead sponsor · 2016-06-01

High Flow Nasal Cannula and Exercise Testing in Chronic Obstructive Pulmonary Disease (COPD)NCT02860273 · lead sponsor · 2016-04-01

High Flow Nasal Cannula and Exercise in Chronic Obstructive Pulmonary Disease (COPD)NCT02858960 · lead sponsor · 2016-04-01

Hemodynamic Changes of Patients Receiving Atenolol/BisoprololNCT01939509 · lead sponsor · 2012-02-01

Hemoglobin A1c and Immediate Postsurgical Complications Diabetes Type 2NCT01403961 · lead sponsor · 2011-07-01

Effectiveness of a High-risk Diabetic Patients ProgramNCT01051245 · lead sponsor · 2010-03-01

Severe Impairment of Solute-Free Water Clearance in Patients With HIV InfectionNCT01869010 · lead sponsor · 2010-01-01

Effectiveness of a Decision Support System in Improving the Diagnosis and Screening Rate of Breast CancerNCT01336257 · lead sponsor · 2009-11-01

Telemonitoring of Uncontrolled HypertensionNCT02730052 · collaborator · 2016-12-01

Drugs studied in this sponsor's trials

4 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Hospital Italiano de Buenos Aires as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

atenolol1

bisoprolol1

ocrelizumab1

semaglutide1

atenolol RxCUI 1202 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial bisoprolol RxCUI 19484 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial ocrelizumab RxCUI 1876366 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial semaglutide RxCUI 1991302 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial

Sponsor roles

lead sponsor24

collaborator1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.